Not finding it? Sign in to also search OpenAlex live.
-
Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study
Morag Griffin, Richard J. Kelly, Mathilde Gavillet, Petra Muus, Britta Hoechsmann, W. Jason Cummings, +4 more
4citations -
OX40L Inhibition Suppresses KLH‐driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof‐of‐Pharmacology for KY10052022 Clinical Pharmacology & Therapeutics article Medicine Cancer Immunotherapy and Biomarkers Open access
Mahdi Saghari, Pim Gal, M Yateman, Ben Porter‐Brown, Nuala Brennan, Sonia Quaratino, +9 more
49citations -
Probabilistic Program Verification via Inductive Synthesis of Inductive Invariants2022 RWTH Publications (RWTH Aachen) conference-paper Computer Science Formal Methods in Verification Open access
Kevin Batz, Mingshuai Chen, Sebastian Junges, Benjamin Lucien Kaminski, Joost-Pieter Katoen, Christoph Matheja
0citations